Insys Therapeutics CEO John Kapoor, 4 Other Execs Found Guilty in Fentanyl Bribery Case

Insys Therapeutics founder John Kapoor leaves federal court in Boston on Jan. 30. (Photo: Steven Senne, AP)
Insys Therapeutics founder John Kapoor leaves federal court in Boston on Jan. 30. (Photo: Steven Senne, AP)

The billionaire founder of the pharmaceutical company Insys Therapeutics and four other top executives were found guilty on Thursday of racketeering in a scheme that involved giving bribes and kickbacks to physicians to prescribe large amounts of a fentanyl spray to patients who didn’t need the painkiller.

After 15 days of deliberations, a jury in Boston federal court reached a verdict in the first-of-its-kind nationwide opioid conspiracy case, finding the CEO and founder John Kapoor of the Arizona-based company guilty of conspiracy charges of racketeering.

Also found guilty  were: Richard M. Simon, the company’s former national director of sales; Sunrise Lee and Joseph A. Rowan, both regional sales directors; and former Vice President of Managed Markets, Michael J. Gurry.

The case in the U.S. District Court of Massachusetts – in which the Justice Department first made indictments in 2016 – is considered the first in federal court involving executives of an opioid manufacturing company.

Click here to continue reading…

SOURCE: Joey Garrison, USA TODAY